David M. Lovinger
- Cellular and Molecular Neuroscience top 0.01%
- Neuroscience and Neuropharmacology Research 185
- Neurotransmitter Receptor Influence on Behavior 104
- Neuroscience and Neural Engineering 21
- Cognitive Neuroscience top 0.2%
- Neural dynamics and brain function 22
- Pharmacology top 0.1%
- Cannabis and Cannabinoid Research 49
- Developmental Neuroscience top 0.5%
- Biological Psychiatry top 1%
-
- Receptor Mechanisms and Signaling 59
- Ion channel regulation and function 56
- Nicotinic Acetylcholine Receptors Study 25
- Co-authors
- Gregory L. GerdemanForrest F. WeightGeoffrey WhiteJennifer RonesiAryeh RouttenbergSukwoo ChoiHenry H. YinBrian A. McCool
- Journals
- Neuropharmacology (19 papers)Journal of Neuroscience (18 papers)Journal of Neurophysiology (14 papers)
- Partner nations
- United StatesSouth KoreaUnited Kingdom
In The Last Decade
David M. Lovinger
259 papers receiving 20.0k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Cellular and Molecular Neuroscience 15.5k
- Cognitive Neuroscience 5.6k
- Pharmacology 3.5k
- Developmental Neuroscience 745
- Biological Psychiatry 380
Countries citing papers authored by David M. Lovinger
This map shows the geographic impact of David M. Lovinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Lovinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Lovinger more than expected).
Fields of papers citing papers by David M. Lovinger
This network shows the impact of papers produced by David M. Lovinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Lovinger. The network helps show where David M. Lovinger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David M. Lovinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 20 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 5 | |
| 7 | 2021 | 8 | |
| 8 | 2021 | 32 | |
| 9 | 2019 | 16 | |
| 10 | 2017 | 130 | |
| 11 | 2015 | 35 | |
| 12 | 2013 | 84 | |
| 13 | 2012 | 6 | |
| 14 | 2012 | 1 | |
| 15 | 2012 | 39 | |
| 16 | 2006 | 400 | |
| 17 | 2005 | 137 | |
| 18 | 1993 | 58 | |
| 19 | 1993 | 68 | |
| 20 | Ethanol (EtOH) inhibition of NMDA-activated ion current is not voltage-dependent and EtOH does not interact with other binding sites on the NMDA receptor/ionophore complex | 1990 | 4 |
About David M. Lovinger
David M. Lovinger is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Pharmacology, having authored 260 papers that have together received 20.4k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (185 papers), Neurotransmitter Receptor Influence on Behavior (104 papers), Receptor Mechanisms and Signaling (59 papers), Ion channel regulation and function (56 papers), Cannabis and Cannabinoid Research (49 papers), Nicotinic Acetylcholine Receptors Study (25 papers), Neural dynamics and brain function (22 papers) and Neuroscience and Neural Engineering (21 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (15.5k citations), Cognitive Neuroscience (5.6k citations) and Pharmacology (3.5k citations). David M. Lovinger has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Gregory L. Gerdeman, Forrest F. Weight, Geoffrey White, Jennifer Ronesi, Aryeh Routtenberg, Sukwoo Choi, Henry H. Yin, Brian A. McCool, Rui M. Costa and Louise Adermark. Their work appears in journals such as Neuropharmacology, Journal of Neuroscience, Journal of Neurophysiology, Neuropsychopharmacology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.